engleski

Adenosine di-phosphate receptor antagonist discontinuation management prior to coronary artery surgery

In this letter to the editor it is shown the importance the time lag in the treatment interruption inhibitor of ADP receptors on platelets in patients treated with revascularization and cardiothoracic possible role determination of platelet function in the risk stratification of ischemic and bleeding complications.

ADP receptor inhibitor; antiplatelet therapy; coronary artery surgery; platelet function tests

nije evidentirano